After Covid, Italians want tailor-made healthcare, modern and in a public-private mix

Tailor-made, innovative and with greater collaboration between public and private. Italians see the healthcare of the future in this way, according to the photograph taken from a report made by Censis in collaboration with Janssen Italia on healthcare in our country, presented on the occasion of the first edition of ‘The Italian Health Day’, which was held today in Rome. The research was carried out as part of the ‘Construction sites for the health of the future’ project, launched in 2021 by Censis and Janssen Italia. Italians seem to have very clear ideas on the characteristics of post-Covid in this sector and on the protagonists who will animate it: citizens who are increasingly informed, responsible and involved; the doctor responsible for health; innovators (researchers and businesses). An ecosystem increasingly oriented towards the personalization of treatments in the triple challenge of managing acute and chronic illnesses and new emergencies, without forgetting economic sustainability. As far as innovation is concerned, almost all people trust scientific researchers (90.9%) and more than 9 out of 10 believe that public spending on health represents an investment and not a cost (93.7 %). Both for scientific experimentation and to ensure that treatments reach patients quickly, cooperation between states and pharmaceutical companies (90%) is essential, as they enjoy the trust of 2 out of 3 Italians (66.4%). Innovators, including companies, are no longer perceived as an external component of healthcare, but as decisive actors who make it possible to optimize the impact on patients’ health and quality of life. The keyword of the Censis report, which expresses shared ideas and expectations at both a social and institutional level, for 2022 is ‘RInnovAzione’: a neologism composed of research, innovation, action and renewal. “The Italians, grateful to healthcare for what it has done in an emergency – said Massimiliano Valerii, general manager of Censis during the presentation – now look at it projected towards the future. Personalization of care, higher outcomes, better quality of life and economic sustainability are the variables of a difficult equation which, if the role of innovators, from researchers to pharmaceutical companies, much appreciated by citizens, is appropriately exploited, will certainly be resolved. Not surprisingly, the majority of Italians are convinced that in The next few years, also thanks to the lessons of this two-year period, the National Health Service is destined to improve. The many future challenges, starting with the need to respond to chronic conditions, acute situations and emergencies, certainly require more resources, more staff, more beds and more services, but in order for everything to be sustainable in the long term, it is crucial to give a strong boost to innovation and research, come on drugs to services in the intelligent use of data, so as to maximize health value “. “We are happy to be able to continue the debate on the health of the future together with Censis,” said Massimo Scaccabarozzi, president of Janssen Italy and Head of External Affairs Johnson & Johnson Italy. “The report presented today – he added – clearly shows what Italians expect from post-Covid healthcare and we can only agree with what they have expressed, starting with the request for greater public-private collaboration to bring more and more quickly innovation for patients. We are also pleased to note that Italians place a high degree of trust in pharmaceutical companies and that their role is recognized in the field of innovation, both in emergencies and in ordinary situations. clinic represents the lifeblood of our company, just think that there are 14 new molecules on which Janssen is working, especially in the oncology and immunology fields, so that they are available to patients “. According to the Italians, the healthcare of the future it will have to be increasingly ‘patient-centric’ and tailor-made: 94.3% hoped for greater personalization of care, with 92.9% expecting that and the treatment pathways, from the home to the territory to the hospitals, are tailored to the personal needs of the patient. “Putting the patient at the center – affirmed Anna Lisa Mandorino, general secretary of Cittadinanzattiva – means reversing the perspective and thinking of health services that reach citizens, are close and widespread in the area, and make use of digitization as a tool to respond in a fast and customized way to their needs. At the same time, especially for the prevention and management of chronic diseases, there must be a very close network of connections between professionals, starting with general practitioners, free pediatricians choice and operators present in the new community homes: in this way we can overcome the challenge of truly strengthening local assistance, as envisaged by the NRP. “The report shows that 9 out of 10 Italians trust doctors (92.1%) and for as many, their figure must be at the center of the healthcare of the future (93.9%). The percentage of citizens who trust the health service of their region is also very high (73.2%). A capital that is projected forward: 61% of Italians are convinced that in the coming years, thanks to the lessons learned from the pandemic, our health will improve. A healthcare system that must be ready not only for possible new emergencies, but also for the socio-demographic forecasts of our country: from the evolution of family forms with the demographic decline and the increase in single-member families, to the lengthening of life expectancy with consequent aging of the population and the multiplication of incapacitating and chronic diseases, which generate high socio-health and assistance needs. The presentation of the report was also attended by Alice Borghini, director of territorial health models organization of the National Agency for Regional Health Services (Agenas), and Daiana Taddeo, national research area of ​​the Italian Society of General Medicine and Primary Care (Simg).